Eloxx Pharmaceuticals Inc (ELOX) Return on Investment ROI from the first quarter of 2026 to first quarter of 2023 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Eloxx Pharmaceuticals Inc   (NASDAQ: ELOX)


Eloxx Pharmaceuticals Inc's ROI from its first quarter of 2026 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Eloxx Pharmaceuticals Inc's ROI in the first quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Eloxx Pharmaceuticals Inc 's return on investment (ROI) in its first quarter of 2026

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Investment Change TTM - - - -93.02 % -75.48 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -8 -12 -17 -15 20
Return On Investment (TTM) - - - - -331.68 %
ELOX's Overall Ranking # # # # #
Seq. Investment Change TTM - - - -77.57 % -10.02 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -4 -6 -20 -24 -31

ELOX Company Profile >> Back to ELOX Roi Comparisons >> See Annual ELOX Return On Investment



Return On Investment ELOX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Eloxx Pharmaceuticals Inc's I. Quarter Investments $ -8 Millions ELOX's Balance sheet
Eloxx Pharmaceuticals Inc's I. Quarter Income $ -4 Millions Quarterly ELOX's Income Statement
ELOX's Income by Division See ELOX's Income by Division


ELOX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions -12 -2 35 17 47
Y / Y Investment Growth - - 111.46 % -64.7 % 9.86 %
Net Income in Millions -6 -36 -67 -35 -51
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - -189.65 % -207.81 % -107.92 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ELOX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ELOX's Competitors
Subscribers only: Roi for Eloxx Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ELOX's Customers

Other Ratios
ELOX's Roa ELOX's Inventory Turnover Ratio ELOX's Growth Rates ELOX's Dividend Statistics
ELOX's Profitability Ratios ELOX's Asset Turnover Ratio ELOX's Dividend Growth
ELOX's Roe ELOX's Valuation Ratios ELOX's Financial Strength Ratios ELOX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Ironwood Pharmaceuticals inc   72.86 %
Lensar Inc   71.13 %
Fortress Biotech Inc   70.93 %
Earth Science Tech Inc   68.75 %
Q32 Bio Inc   58.17 %
Oramed Pharmaceuticals Inc  54.33 %
Aurinia Pharmaceuticals Inc   54.02 %
Vaxart Inc   51.45 %
Escalon Medical Corp   51.07 %
Tg Therapeutics Inc   50.62 %
Zevra Therapeutics Inc   50.45 %
Idexx Laboratories Inc  50.05 %
Theravance Biopharma inc   43.85 %
Elite Pharmaceuticals Inc   43.22 %
Dariohealth Corp   40.59 %
Innoviva Inc   36.71 %
Indivior Pharmaceuticals Inc   36.55 %
Eli Lilly And Company  36.13 %
Abeona Therapeutics Inc   35.03 %
Lifemd Inc   34.80 %
Acadia Pharmaceuticals Inc   34.03 %
Mettler toledo International Inc   33.62 %
Adma Biologics Inc   30.38 %
Medpace Holdings Inc   30.34 %
Spero Therapeutics Inc   29.59 %
Rafael Holdings Inc  28.08 %
Incyte Corporation  27.50 %
Carlisle Companies Incorporated  24.39 %
Iradimed Corporation  23.59 %
Catalyst Pharmaceuticals Inc   23.58 %

Date modified: 2026-08-30T14:40:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.